Skip to main content

Advertisement

Log in

Prophylactic Antibiotics Versus Immunoglobulin Replacement in Specific Antibody Deficiency

  • Original Article
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Purpose

Prophylactic antibiotics (PA) and immunoglobulin replacement (IGRT) are commonly used in specific antibody deficiency (SAD); however, optimal treatment is not well-established. Our purpose is to compare treatment outcomes with IGRT and/or PA among SAD patients.

Methods

A retrospective chart review of SAD patients treated at two tertiary centers between January 2012 and May 2017 was performed. Clinical and laboratory data, and rates of infections prior to and after treatment with IGRT or PA were analyzed. Descriptive analyses, between-group comparisons of rates of infection after 1 year of treatment, and a stepwise logistic regression model were employed to explore factors contributing to treatment outcomes.

Results

We identified 65 SAD patients with mean age were 18 years (2–71 years). The baseline mean number of infections in the PA group and IGRT group was 4.71 (SD 3.15) and 7.73 (SD 6.65), respectively. Twenty-nine (44.6%) received IGRT, 7 (10.7%) received PA, 7 (10.7%) received both IGRT and PA, 15 (23.1%) failed PA and switched to IGRT, and 7 did not receive any specific treatment. After 1 year of treatment, the difference in the mean number of infections in PA vs. IGRT was not statistically significant [2.86 (2.73) vs. 4.44 (4.74), p = 0.27]. Reporting autoimmunity increased the odds for persistent infections (OR = 4.29; p = 0.047), while higher IgG levels decreased the odds for persistent infections (OR = 0.68, p = 0.018).

Conclusions

PA and IGRT are equally effective as first line in preventing infections in SAD patients. However, patients who fail PA would benefit from IGRT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

SAD:

Specific antibody deficiency

PA:

Prophylactic antibiotics

IGRT:

Immunoglobulin replacement therapy

TCH:

Texas Children’s Hospital

CHOP:

Children’s Hospital Philadelphia

PID:

Primary immunodeficiency

References

  1. Ambrosino DM, Siber GR, Chilmonczyk BA, Jernberg JB, Finberg RW. An immunodeficiency characterized by impaired antibody responses to polysaccharides. N Engl J Med. 1987;316:790–3.

    Article  CAS  Google Scholar 

  2. Epstein MM, Gruskay F. Selective deficiency in pneumococcal antibody response in children with recurrent infections. Ann Allergy Asthma Immunol. 1995;75:125–31.

    CAS  PubMed  Google Scholar 

  3. Zora JA, Silk HJ, Tinkelman DG. Evaluation of postimmunization pneumococcal titers in children with recurrent infections and normal levels of immunoglobulin. Ann Allergy. 1993;70:283–8.

    CAS  PubMed  Google Scholar 

  4. Sanders LA, Rijkers GT, Kuis W, Tenbergen-Meekes AJ, de Graeff-Meeder BR, Hiemstra I, et al. Defective antipneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections. J Allergy Clin Immunol. 1993;91:110–9.

    Article  CAS  Google Scholar 

  5. Hidalgo H, Moore C, Leiva LE, Sorensen RU. Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections. Ann Allergy Asthma Immunol. 1996;76:341–6.

    Article  CAS  Google Scholar 

  6. Gross S, Blaiss MS, Herrod HG. Role of immunoglobulin subclasses and specific antibody determinations in the evaluation of recurrent infection in children. J Pediatr. 1992;121:516–22.

    Article  CAS  Google Scholar 

  7. Orange JS, Ballow M, Stiehm ER, Ballas ZK, Chinen J, De La Morena M, et al. Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2012;130:S1–24.

    Article  Google Scholar 

  8. Perez E, Bonilla FA, Orange JS, Ballow M. Specific antibody deficiency: controversies in diagnosis and management. Front Immunol. 2017;8:586.

    Article  Google Scholar 

  9. Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM, Hsu JT, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2015;136:1186–205 e1-78.

    Article  Google Scholar 

  10. Javier FC III, Moore CM, Sorensen RU. Distribution of primary immunodeficiency diseases diagnosed in a pediatric tertiary hospital. Ann Allergy Asthma Immunol. 2000;84:25–30.

    Article  Google Scholar 

  11. Modell V, Knaus M, Modell F, Roifman C, Orange J, Notarangelo LD. Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discovery. Immunol Res. 2014;60:132–44.

    Article  CAS  Google Scholar 

  12. Bonilla FA, Bernstein IL, Khan DA, Ballas ZK, Chinen J, Frank MM, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol. 2005;94:S1–63.

    Article  Google Scholar 

  13. Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM, Hsu JT, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2015;136:1186–205 e78.

    Article  Google Scholar 

  14. Leiva LE, Monjure H, Sorensen RU. Recurrent respiratory infections, specific antibody deficiencies, and memory B cells. J Clin Immunol. 2013;33(Suppl 1):S57–61.

    Article  Google Scholar 

  15. Orange JS, Ochs HD, Cunningham-Rundles C. Prioritization of evidence-based indications for intravenous immunoglobulin. J Clin Immunol. 2013;33:1033–6.

    Article  Google Scholar 

  16. Bayry J, Kazatchkine MD, Kaveri SV. Shortage of human intravenous immunoglobulin—reasons and possible solutions. Nat Clin Pract Neurol. 2007;3:120–1.

    Article  Google Scholar 

  17. Orange JS, Grossman RJ, Navickis MM, Wilkes WJ. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies. Clin Immunol. 2010;137:21–30 SRC - GoogleScholar.

    Article  CAS  Google Scholar 

  18. Azizi G, Ahmadi M, Abolhassani H, Yazdani R, Mohammadi H, Mirshafiey A, et al. Autoimmunity in primary antibody deficiencies. Int Arch Allergy Immunol. 2016;171:180–93.

    Article  CAS  Google Scholar 

  19. Farmer JR, Ong MS, Barmettler S, Yonker LM, Fuleihan R, Sullivan KE, et al. Common variable immunodeficiency non-infectious disease endotypes redefined using unbiased network clustering in large electronic datasets. Front Immunol. 2017;8:1740.

    Article  Google Scholar 

  20. Wilson SP, Ballas ZK. Progression of specific antibody deficiency (SAD) to common variable immunodeficiency (CVID). J Allergy Clin Immunol. 2010;125:AB73.

    Article  Google Scholar 

Download references

Acknowledgments

The research is partially supported by the Jeffery Modell Foundation, and supported in part by the Intramural Research Program of the NIH, NIAID. Joud Hajjar received the USIDnet and the Clinical immunology society travel grants for an oral presentation summarizing this work.

Authorship Contributions

Conceptualization: [Joud Hajjar]; Methodology: [Joud Hajjar], Formal analysis and investigation: [Joud Hajjar, Carleigh Kutac, An Nguyen, Gregory Constantine, Maha Syed and Kathleen Sullivan], Writing—original draft preparation: [Joud Hajjar, Maha Syed]; Writing—review and editing: [all authors]; Supervision: [Joud Hajjar, Jordan Orange and Kathleen Sullivan].

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joud Hajjar.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 24 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Joud Hajjar, Nguyen, A.L., Constantine, G. et al. Prophylactic Antibiotics Versus Immunoglobulin Replacement in Specific Antibody Deficiency. J Clin Immunol 40, 158–164 (2020). https://doi.org/10.1007/s10875-019-00716-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-019-00716-2

Keywords

Navigation